Lexicon Pharmaceuticals
LXRX
#7142
Rank
S$0.65 B
Marketcap
S$1.81
Share price
-1.41%
Change (1 day)
108.52%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total debt

Total debt on the balance sheet as of September 2025 : S$75.35 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is S$75.35 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Lexicon Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$0.14 B5.18%
2023-12-31S$0.14 B88.97%
2022-12-31S$74.12 M2305.94%
2021-12-31S$3.08 M-81.82%
2020-12-31S$16.94 M-94.88%
2019-12-31S$0.33 B-1.02%
2018-12-31S$0.33 B1.86%
2017-12-31S$0.32 B123.79%
2016-12-31S$0.14 B0.84%
2015-12-31S$0.14 B2.35%
2014-12-31S$0.14 B413.26%
2013-12-31S$27.71 M-3.35%
2012-12-31S$28.67 M-11.04%
2011-12-31S$32.23 M-12.13%
2010-12-31S$36.68 M-60.97%
2009-12-31S$94.01 M115.59%
2008-12-31S$43.6 M-3.41%
2007-12-31S$45.14 M-8.53%
2006-12-31S$49.35 M-19.75%
2005-12-31S$61.5 M0.19%
2004-12-31S$61.39 M-35.87%
2003-12-31S$95.72 M1279.25%
2002-12-31S$6.94 M
2000-12-31S$4.93 M-38%
1999-12-31S$7.95 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
S$0.71 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$3.50 B 4,552.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S$43.84 M-41.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.78 B 939.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$46.23 B 61,258.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.39 B 427.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$3.33 B 4,329.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.58 B 675.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S$0.43 B 479.51%๐Ÿ‡บ๐Ÿ‡ธ USA